Literature DB >> 21500120

Lung cancer in never smokers.

Ping Yang1.   

Abstract

Lung cancer in never smokers (LCINS) has lately been recognized as a unique disease based on rapidly gained knowledge from genomic changes to treatment responses. The focus of this article is on current knowledge and challenges with regard to LCINS expanded from recent reviews highlighting five areas: (1) distribution of LCINS by temporal trends, geographic regions, and populations; (2) three well-recognized environmental risk factors; (3) other plausible environmental risk factors; (4) prior chronic lung diseases and infectious diseases as risk factors; and (5) lifestyles as risk or protective factors. This article will also bring attention to recently published literature in two pioneering areas: (1) histological characteristics, clinical features with emerging new effective therapies, and social and psychological stigma; and (2) searching for susceptibility genes using integrated genomic approaches. © Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2011        PMID: 21500120      PMCID: PMC3404817          DOI: 10.1055/s-0031-1272865

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  145 in total

1.  Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer.

Authors:  Jennifer S Smith; Urban Kumlin; Fredrik Nyberg; Cristina Fortes; David Zaridze; Wolfgang Ahrens; Irene Bruske-Hohlfeld; Vali Constantinescu; Jie Ting; Simone Benhamou; Lorenzo Simonato; Jens Boman; Valerie Gaborieau; Paolo Boffetta
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

2.  Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer.

Authors:  A L Laurila; T Anttila; E Läärä; A Bloigu; J Virtamo; D Albanes; M Leinonen; P Saikku
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

Review 3.  Does interstitial lung disease predispose to lung cancer?

Authors:  Craig E Daniels; James R Jett
Journal:  Curr Opin Pulm Med       Date:  2005-09       Impact factor: 3.155

4.  Female sex and oral contraceptive use accelerate nicotine metabolism.

Authors:  Neal L Benowitz; Christina N Lessov-Schlaggar; Gary E Swan; Peyton Jacob
Journal:  Clin Pharmacol Ther       Date:  2006-05       Impact factor: 6.875

5.  Lung cancer incidence in never smokers.

Authors:  Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

6.  Assessment of human papillomavirus and Epstein-Barr virus in lung adenocarcinoma.

Authors:  Wan-Teck Lim; Khoon Leong Chuah; Swan Swan Leong; Eng Huat Tan; Chee Keong Toh
Journal:  Oncol Rep       Date:  2009-04       Impact factor: 3.906

7.  Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer.

Authors:  Pengyuan Liu; Haris G Vikis; Daolong Wang; Yan Lu; Yian Wang; Ann G Schwartz; Susan M Pinney; Ping Yang; Mariza de Andrade; Gloria M Petersen; Jonathan S Wiest; Pamela R Fain; Adi Gazdar; Colette Gaba; Henry Rothschild; Diptasri Mandal; Teresa Coons; Juwon Lee; Elena Kupert; Daniela Seminara; John Minna; Joan E Bailey-Wilson; Xifeng Wu; Margaret R Spitz; Timothy Eisen; Richard S Houlston; Christopher I Amos; Marshall W Anderson; Ming You
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

Review 8.  Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition.

Authors:  David R Gandara; Howard West; Kari Chansky; Angela M Davies; Derick H M Lau; John Crowley; Paul H Gumerlock; Fred R Hirsch; Wilbur A Franklin
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

9.  Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.

Authors:  Z Tang; R Du; S Jiang; C Wu; D S Barkauskas; J Richey; J Molter; M Lam; C Flask; S Gerson; A Dowlati; L Liu; Z Lee; B Halmos; Y Wang; J A Kern; P C Ma
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

10.  Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).

Authors:  Roland T Ullrich; Thomas Zander; Bernd Neumaier; Mirjam Koker; Takeshi Shimamura; Yannic Waerzeggers; Christa L Borgman; Samir Tawadros; Hongfeng Li; Martin L Sos; Heiko Backes; Geoffrey I Shapiro; Jürgen Wolf; Andreas H Jacobs; Roman K Thomas; Alexandra Winkeler
Journal:  PLoS One       Date:  2008-12-12       Impact factor: 3.240

View more
  11 in total

Review 1.  Human papillomavirus and lung cancinogenesis: an overview.

Authors:  Antonio Carlos de Freitas; Ana Pavla Gurgel; Elyda Golçalves de Lima; Bianca de França São Marcos; Carolina Maria Medeiros do Amaral
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-29       Impact factor: 4.553

Review 2.  Lung cancer: epidemiology, etiology, and prevention.

Authors:  Charles S Dela Cruz; Lynn T Tanoue; Richard A Matthay
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

3.  Discovery and validation of potential bacterial biomarkers for lung cancer.

Authors:  Xinmin Yan; Mingxia Yang; Juan Liu; Ruichen Gao; Jihong Hu; Jiong Li; Lijun Zhang; Yujia Shi; Hongrong Guo; Jinluo Cheng; Miriam Razi; Shen Pang; Xiaowei Yu; Shen Hu
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

4.  Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma.

Authors:  R Taylor Ripley; Robert R McMillan; Camelia S Sima; Saad M Hasan; Usman Ahmad; Feiran Lou; David R Jones; Valerie W Rusch; Nabil P Rizk; James Huang
Journal:  Ann Thorac Surg       Date:  2014-07-16       Impact factor: 4.330

5.  Individual and combined effect of TP53, MDM2, MDM4, MTHFR, CCR5, and CASP8 gene polymorphisms in lung cancer.

Authors:  Ausra Stumbryte; Zivile Gudleviciene; Gabrielis Kundrotas; Daiva Dabkeviciene; Agne Kunickaite; Saulius Cicenas
Journal:  Oncotarget       Date:  2017-11-29

Review 6.  The barriers to initiating lung cancer care in low-and middle-income countries.

Authors:  Buhle Lubuzo; Themba Ginindza; Khumbulani Hlongwana
Journal:  Pan Afr Med J       Date:  2020-02-12

Review 7.  Occupational pesticide exposures and respiratory health.

Authors:  Ming Ye; Jeremy Beach; Jonathan W Martin; Ambikaipakan Senthilselvan
Journal:  Int J Environ Res Public Health       Date:  2013-11-28       Impact factor: 3.390

8.  Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.

Authors:  Sheng Yang; Jing Sui; Geyu Liang
Journal:  PeerJ       Date:  2017-11-30       Impact factor: 2.984

9.  Occupational Exposure to Pesticides and Lung Cancer Risk: A Propensity Score Analyses.

Authors:  Byungmi Kim; Eun Young Park; Jinsun Kim; Eunjung Park; Jin-Kyoung Oh; Min Kyung Lim
Journal:  Cancer Res Treat       Date:  2021-03-31       Impact factor: 4.679

10.  Epidermal Growth Factor Receptor Gene Mutation Detection in Histology and Cytology Specimens of Primary Lung Adenocarcinoma: Immunohistochemistry Versus the Molecular Method.

Authors:  Nurul Shuhada Abdul Hamid; Anani Aila Mat Zin
Journal:  Asian Pac J Cancer Prev       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.